Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LALITA CHULAMOKHA

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1326201682
CMS profile
1141687
Location
FORT MYERS, FL

General Payments · PY2019–2024

$1,653.70

  • Reported across 71 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$359.37

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $359.37 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Shionogi Inc $108.83 4
Melinta Therapeutics, Inc. $71.03 3
Merck Sharp & Dohme Corporation $67.00 2
ViiV Healthcare Company $59.21 3
AIMMUNE THERAPEUTICS, INC. $31.20 1
Insmed, Inc. $22.10 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $31.69 1
PY2020 $61.89 3
PY2021 $518.19 25
PY2022 $264.63 11
PY2023 $417.93 17
PY2024 $359.37 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AIMMUNE THERAPEUTICS, INC. $31.20 10/03/2024 Food and Beverage Undisputed 01/23/2026 1146999492 CMS
Insmed, Inc. $22.10 04/25/2024 Food and Beverage Undisputed 01/23/2026 1089557092 CMS
Melinta Therapeutics, LLC $22.44 03/19/2024 Food and Beverage Undisputed 01/23/2026 1140483704 CMS
Melinta Therapeutics, LLC $25.59 06/04/2024 Food and Beverage Undisputed 01/23/2026 1140485099 CMS
Melinta Therapeutics, LLC $23.00 10/24/2024 Food and Beverage Undisputed 01/23/2026 1140484002 CMS
Merck Sharp & Dohme LLC $34.87 06/20/2024 Food and Beverage Undisputed 01/23/2026 1141871325 CMS
Merck Sharp & Dohme LLC $32.13 08/27/2024 Food and Beverage Undisputed 01/23/2026 1141706828 CMS
Shionogi Inc $24.43 04/09/2024 Food and Beverage Undisputed 01/23/2026 1154334692 CMS
Shionogi Inc $32.10 06/11/2024 Food and Beverage Undisputed 01/23/2026 1154334722 CMS
Shionogi Inc $29.00 07/02/2024 Food and Beverage Undisputed 01/23/2026 1154334740 CMS
Shionogi Inc $23.30 10/01/2024 Food and Beverage Undisputed 01/23/2026 1154334766 CMS
ViiV Healthcare Company $20.07 06/25/2024 Food and Beverage Undisputed 01/23/2026 1112708694 CMS
ViiV Healthcare Company $22.76 06/26/2024 Food and Beverage Undisputed 01/23/2026 1112807319 CMS
ViiV Healthcare Company $16.38 07/11/2024 Food and Beverage Undisputed 01/23/2026 1112740513 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.